Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Photocure ASA

PHCUFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$7.00
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Photocure ASA Fundamental Analysis

Photocure ASA (PHCUF) shows moderate financial fundamentals with a PE ratio of -1158.37, profit margin of -0.29%, and ROE of -0.32%. The company generates $0.5B in annual revenue with moderate year-over-year growth of 4.94%.

Key Strengths

Cash Position128.65%
PEG Ratio0.41
Current Ratio3.64

Areas of Concern

ROE-0.32%
We analyze PHCUF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 36.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
36.0/100

We analyze PHCUF's fundamental strength across five key dimensions:

Efficiency Score

Weak

PHCUF struggles to generate sufficient returns from assets.

ROA > 10%
-0.22%

Valuation Score

Excellent

PHCUF trades at attractive valuation levels.

PE < 25
-1158.37
PEG Ratio < 2
0.41

Growth Score

Weak

PHCUF faces weak or negative growth trends.

Revenue Growth > 5%
4.94%
EPS Growth > 10%
-5.71%

Financial Health Score

Excellent

PHCUF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
3.64

Profitability Score

Weak

PHCUF struggles to sustain strong margins.

ROE > 15%
-31.88%
Net Margin ≥ 15%
-0.29%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PHCUF Expensive or Cheap?

P/E Ratio

PHCUF trades at -1158.37 times earnings. This suggests potential undervaluation.

-1158.37

PEG Ratio

When adjusting for growth, PHCUF's PEG of 0.41 indicates potential undervaluation.

0.41

Price to Book

The market values Photocure ASA at 3.66 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.66

EV/EBITDA

Enterprise value stands at 28.51 times EBITDA. This signals the market has high growth expectations.

28.51

How Well Does PHCUF Make Money?

Net Profit Margin

For every $100 in sales, Photocure ASA keeps $-0.29 as profit after all expenses.

-0.29%

Operating Margin

Core operations generate 10.21 in profit for every $100 in revenue, before interest and taxes.

10.21%

ROE

Management delivers $-0.32 in profit for every $100 of shareholder equity.

-0.32%

ROA

Photocure ASA generates $-0.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Photocure ASA generates limited operating cash flow of $31.40M, signaling weaker underlying cash strength.

$31.40M

Free Cash Flow

Photocure ASA produces free cash flow of $28.79M, offering steady but limited capital for shareholder returns and expansion.

$28.79M

FCF Per Share

Each share generates $1.08 in free cash annually.

$1.08

FCF Yield

PHCUF converts 1.61% of its market value into free cash.

1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1158.37

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.41

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.66

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.34

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How PHCUF Stacks Against Its Sector Peers

MetricPHCUF ValueSector AveragePerformance
P/E Ratio-1158.3729.78 Better (Cheaper)
ROE-0.32%792.00% Weak
Net Margin-0.29%-23280.00% (disorted) Weak
Debt/Equity0.000.25 Strong (Low Leverage)
Current Ratio3.644.60 Strong Liquidity
ROA-0.22%-18077.00% (disorted) Weak

PHCUF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Photocure ASA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

49.92%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-112.14%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

198.55%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ